Skip to content

Clinical trials

Phase 1 Prostatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Country / region: Japan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20121
20141
20151
20191
20202
20211
20232
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting6
Recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Amgen2
Bayer2
Janssen Pharmaceutical K.K.2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Alterome Therapeutics, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms20
Neoplasm Metastasis6
Breast Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Triple Negative Breast Neoplasms3
Uterine Cervical Neoplasms3
Bites and Stings2
Bulbo-Spinal Atrophy, X-Linked2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.